We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advisory Council on the Misuse of Drugs (ACMD) call for evidence on cannabinoids in CBD products.
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
Government response to the ACMD's review of the evidence on the use and harms of Cumyl-PeGaClone.
Barriers to Research working group calls for written evidence about barriers to legitimate research for controlled drugs, excluding synthetic cannabinoids.
Advice to Lord Darren Mott OBE, former Government Whip in the House of Lords, on business appointments after leaving Crown service.
Report examining issues relating to road safety and the use and prescription of medical cannabis.
Guidance on manufacturing, importing, distributing and supplying specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials'
The Advisory Council on the Misuse of Drugs has undertaken a review of the evidence on the use and harms of Cumyl-PeGaClone.
A Change to the Misuse of Drugs Act 1971: control of synthetic cannabinoids and related compounds.
This circular draws attention to the content of the Statutory Instruments SI 2019/1323 and SI 2019/1362.
Report to the Minister for Crime Prevention, which recommends a revised generic description of ‘third generation’ synthetic cannabinoids.
Fifth webinar in the Webinar Series of the Joint Knowledge Transfer Framework for Food Standards and Food Safety Analysis on 29 March 2023
Lynne Featherstone writes to the ACMD chair regarding synthetic cannabinoids.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).